CME GROUP INC. (CME) financial statements: income statement, balance sheet and cash flow

CME GROUP INC.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), CME GROUP INC. reported revenue of $6.5B (+6.4% year on year) and net income of $4.1B (+15.5% year on year).

Income statement

CME GROUP INC. income statement, fiscal years

Line item	Dec 31, 2025 · FY	Dec 31, 2024 · FY	Dec 31, 2023 · FY	Dec 31, 2022 · FY
Total Revenues	$6.5B	$6.1B	$5.6B	$5.0B
Compensation and benefits	$907.0M	$850.3M	$828.6M	$753.1M
Technology	$283.2M	$255.8M	$218.7M	$188.6M
Professional fees and outside services	$150.5M	$132.7M	$144.4M	$137.4M
Amortization of purchased intangibles	$223.4M	$221.7M	$226.6M	$227.7M
Depreciation and amortization	$107.5M	$115.1M	$126.0M	$134.9M
Licensing and other fee agreements	$371.0M	$355.4M	$322.8M	$320.0M
Other	$248.5M	$267.6M	$276.1M	$241.8M
Total Expenses	$2.3B	$2.2B	$2.1B	$2.0B
Operating Income	$4.2B	$3.9B	$3.4B	$3.0B
Investment income	$5.7B	$4.1B	$5.3B	$2.2B
Interest and other borrowing costs	($173.4M)	($160.9M)	($159.4M)	($162.7M)
Equity in net earnings (losses) of unconsolidated subsidiaries	$371.7M	$350.9M	$296.9M	$301.1M
Other income (expense)	($4.8B)	($3.7B)	($4.7B)	($1.9B)
Total Non-Operating	$1.1B	$609.9M	$717.9M	$474.4M
Income before Income Taxes	$5.3B	$4.5B	$4.2B	$3.5B
Income tax provision	$1.3B	$1.0B	$927.4M	$799.3M
Net income	$4.1B	$3.5B	$3.2B	$2.7B
Net income attributable to CME Group	$4.1B	$3.5B	$3.2B	$2.7B
Net Income Attributable to Common Shareholders of CME Group	$4.0B	$3.5B	$3.2B	$2.7B
Basic	$11.18	$9.69	$8.87	$7.41
Diluted	$11.16	$9.67	$8.86	$7.40
Basic	359.6M	359.4M	359.0M	358.7M
Diluted	360.3M	359.9M	359.5M	359.2M

CME GROUP INC. income statement, quarters

Line item	Sep 30, 2026 · Q3	Jun 30, 2026 · Q2	Mar 31, 2026 · Q1	Sep 30, 2025 · Q3
Total Revenues	$1.7B	$1.7B	$1.9B	$1.5B
Compensation and benefits	$234.3M	$233.5M	$223.0M	$237.6M
Technology	$80.9M	$83.3M	$76.6M	$71.4M
Professional fees and outside services	$31.1M	$29.1M	$28.2M	$36.7M
Amortization of purchased intangibles	$56.0M	$56.0M	$56.1M	$56.2M
Depreciation and amortization	$27.4M	$28.2M	$27.2M	$26.4M
Licensing and other fee agreements	$104.2M	$109.1M	$106.8M	$81.6M
Other	$62.0M	$59.9M	$52.5M	$55.1M
Total Expenses	$595.9M	$599.1M	$570.4M	$565.0M
Operating Income	$1.1B	$1.1B	$1.3B	$972.6M
Investment income	$1.4B	$1.4B	$1.4B	$1.5B
Interest and other borrowing costs	($43.5M)	($43.6M)	($43.6M)	($44.0M)
Equity in net earnings of unconsolidated subsidiaries	$102.8M	$97.7M	$102.4M	$96.3M
Other non-operating income (expense)	($1.3B)	($1.3B)	($1.2B)	($1.4B)
Total Non-Operating Income (Expense)	$213.4M	$220.6M	$201.2M	$204.4M
Income before Income Taxes	$1.4B	$1.3B	$1.5B	$1.2B
Income tax provision	$317.9M	$285.9M	$356.6M	$269.0M
Net Income	$1.0B	$1.0B	$1.2B	$908.0M
Basic (in dollars per share)	$2.90	$2.89	$3.25	$2.49
Diluted (in dollars per share)	$2.89	$2.88	$3.18	$2.49
Basic (in shares)	358.0M	360.7M	359.3M	359.7M
Diluted (in shares)	358.6M	361.3M	363.2M	360.4M

Balance sheet

CME GROUP INC. balance sheet, fiscal years

Line item	Dec 31, 2025 · FY	Dec 31, 2024 · FY	Dec 31, 2023 · FY	Dec 31, 2022 · FY
Cash and cash equivalents	$4.4B	$2.9B	$2.9B	$2.7B
Marketable securities	$125.0M	$113.2M	$111.7M	$96.0M
Accounts receivable, net of allowance	$639.2M	$573.1M	$535.6M	$483.2M
Other current assets	$522.1M	$559.4M	$1.1B	$529.8M
Total current assets	$165.4B	$103.0B	$94.9B	$139.1B
Property, net of accumulated depreciation and amortization	$362.7M	$386.2M	$409.5M	$455.5M
Intangible assets-trading products	$17.2B	$17.2B	$17.2B	$17.2B
Intangible assets—other, net	$2.6B	$2.8B	$3.1B	$3.3B
Goodwill	$10.5B	$10.5B	$10.5B	$10.5B
Other assets	$2.4B	$3.5B	$3.7B	$3.7B
Total Assets	$198.4B	$137.4B	$129.7B	$174.2B
Accounts payable	$71.8M	$79.9M	$90.6M	$121.4M
Short-term debt	$0	$749.8M	$0	$16.0M
Other current liabilities	$568.8M	$2.6B	$3.1B	$2.3B
Performance bonds and guaranty fund contributions	$159.7B	$98.9B	$90.2B	$135.2B
Total current liabilities	$160.3B	$102.3B	$93.4B	$137.7B
Long-term debt	$3.4B	$2.7B	$3.4B	$3.4B
Deferred Income Tax Liabilities, Net	$5.2B	$5.2B	$5.3B	$5.4B
Other liabilities	$734.8M	$721.2M	$798.2M	$826.0M
Total Liabilities	$169.7B	$111.0B	$103.0B	$147.3B
Preferred stock, $0.01 par value, 10,000 shares authorized, none issued or outstanding	0	0	0	0
Common stock	$3.6M	$3.6M	$3.6M	$3.6M
Additional paid-in capital	$22.2B	$22.4B	$22.3B	$22.3B
Retained earnings	$6.4B	$4.2B	$4.5B	$4.7B
Accumulated other comprehensive income (loss)	$81.9M	($105.5M)	($55.6M)	($133.3M)
Total CME Group Shareholders' Equity	$28.7B	$26.5B	$26.7B	$26.9B
Total Liabilities and Shareholders' Equity	$198.4B	$137.4B	$129.7B	$174.2B

CME GROUP INC. balance sheet, quarters

Line item	Sep 30, 2026	Jun 30, 2026	Mar 31, 2026	Sep 30, 2025
Cash and cash equivalents	$2.2B	$2.1B	$2.4B	$2.4B
Marketable securities	$131.0M	$131.4M	$124.2M	$123.2M
Accounts receivable, net of allowance of $9.1 and $10.0	$788.1M	$753.1M	$935.5M	$642.9M
Other current assets (includes $3.5 and $6.5 in restricted cash)	$840.9M	$491.7M	$515.0M	$546.7M
Total current assets	$159.1B	$161.6B	$169.0B	$152.8B
Property, net of accumulated depreciation and amortization of $1,019.5 and $1,005.7	$338.7M	$351.2M	$355.4M	$355.2M
Intangible assets—trading products	$17.2B	$17.2B	$17.2B	$17.2B
Intangible assets—other, net	$2.4B	$2.5B	$2.6B	$2.7B
Goodwill	$10.5B	$10.5B	$10.5B	$10.5B
Other assets	$2.5B	$2.5B	$2.4B	$3.6B
Total Assets	$192.1B	$194.7B	$202.0B	$187.1B
Accounts payable	$67.7M	$68.0M	$75.4M	$74.9M
Other current liabilities	$865.5M	$538.6M	$887.1M	$471.1M
Performance bonds and guaranty fund contributions	$155.2B	$158.1B	$165.0B	$149.0B
Total current liabilities	$156.1B	$158.7B	$166.0B	$149.6B
Long-term debt	$3.4B	$3.4B	$3.4B	$3.4B
Deferred income tax liabilities, net	$5.2B	$5.2B	$5.2B	$5.2B
Other liabilities	$785.6M	$793.8M	$733.2M	$725.7M
Total Liabilities	$165.5B	$168.2B	$175.4B	$159.0B
Preferred stock, $0.01 par value, 10,000 shares authorized at September 30, 2026 and December 31, 2025; no shares issued and outstanding as of September 30, 2026 and 4,584 issued and outstanding as of December 31, 2025	0	0	0	0
Common stock	$3.6M	$3.6M	$3.6M	$3.6M
Additional paid-in capital	$20.5B	$21.0B	$21.7B	$22.4B
Retained earnings	$6.0B	$5.5B	$4.9B	$5.7B
Accumulated other comprehensive income (loss)	$55.5M	$54.9M	$59.4M	$43.4M
Total CME Group Shareholders’ Equity	$26.6B	$26.5B	$26.6B	$28.2B
Total Liabilities and Equity	$192.1B	$194.7B	$202.0B	$187.1B

Cash flow statement

CME GROUP INC. cash flow statement, fiscal years

Line item	Dec 31, 2025 · FY	Dec 31, 2024 · FY	Dec 31, 2023 · FY	Dec 31, 2022 · FY
Net income	$4.1B	$3.5B	$3.2B	$2.7B
Stock-based compensation	$94.8M	$89.5M	$82.9M	$84.3M
Amortization of purchased intangibles	$223.4M	$221.7M	$226.6M	$227.7M
Depreciation and amortization	$107.5M	$115.1M	$126.0M	$134.9M
Net realized and unrealized gains on investments	($352.8M)	($3.6M)	($72.1M)	($4.8M)
Deferred income taxes	($6.1M)	($66.4M)	($75.0M)	($23.2M)
Accounts receivable	($67.1M)	($39.4M)	($51.5M)	($51.1M)
Other current assets	($18.1M)	$664.8M	($637.8M)	($76.5M)
Other assets	$49.9M	$75.4M	$92.0M	$87.0M
Accounts payable	($8.1M)	($10.7M)	($30.8M)	$72.5M
Income tax payable	$91.1M	($117.4M)	($77.1M)	($147.8M)
Other current liabilities	$86.6M	($705.9M)	$642.7M	$88.1M
Other liabilities	($34.6M)	($55.4M)	($32.7M)	($67.4M)
Other	$38.4M	($3.0M)	$34.4M	$41.3M
Net Cash Provided by Operating Activities	$4.3B	$3.7B	$3.5B	$3.1B
Proceeds from maturities and sales of available-for-sale marketable securities	$7.9M	$6.0M	$5.9M	$6.3M
Purchases of available-for-sale marketable securities	$6.0M	$4.5M	$4.1M	$4.4M
Purchases of property, net	($83.5M)	($94.0M)	($76.4M)	($89.7M)
Investments in business ventures	$11.0M	$3.6M	$2.4M	$3.1M
Proceeds from sale of business ventures	$1.6B	$13.5M	$97.9M	$11.1M
Net Cash Used in Investing Activities	$1.5B	($82.6M)	$20.9M	($489.8M)
Proceeds from debt, net of issuance costs	$740.6M	$0	$0	$741.0M
Repayment of other borrowings, including call premiums	($750.0M)	$0	($16.4M)	($756.2M)
Cash dividends	($3.9B)	($3.6B)	($3.2B)	($2.6B)
Payments for (Proceeds from) Derivative Instrument, Financing Activities	($266.1M)	—	—	—
Change in performance bond and guaranty fund contributions	$60.8B	$8.7B	($45.1B)	($22.7B)
Employee taxes paid on restricted stock vesting	($33.9M)	($33.0M)	($21.4M)	($24.8M)
Other	($8.7M)	($9.2M)	($9.3M)	($7.9M)
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	$56.5B	$5.1B	($48.3B)	($25.4B)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$62.3B	$8.7B	($44.9B)	($22.8B)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning Balance	$101.8B	$93.1B	$138.0B	$160.8B
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Ending Balance	$164.1B	$101.8B	$93.1B	$138.0B
Cash and cash equivalents	$4.4B	$2.9B	$2.9B	$2.7B
Short-term restricted cash (within other current assets)	$6.5M	$6.3M	$5.2M	$4.9M
Long-term restricted cash (within other assets)	$0	$0	$0	$100.0K
Restricted cash and restricted cash equivalents (performance bonds and guaranty fund contributions)	$159.7B	$98.9B	$90.2B	$135.2B
Income taxes paid	$1.2B	$1.2B	$1.1B	$973.4M
Interest paid	$135.6M	$129.9M	$129.9M	$133.2M
Dividends declared	$0	$2.1B	$1.9B	$1.6B

CME GROUP INC. cash flow statement, quarters

Line item	Sep 30, 2026 · YTD	Jun 30, 2026 · YTD	Mar 31, 2026 · Q1	Sep 30, 2025 · YTD
Net Income	$3.2B	$2.2B	$1.2B	$2.9B
Stock-based compensation	$70.7M	$46.6M	$21.8M	$65.9M
Amortization of purchased intangibles	$168.1M	$112.1M	$56.1M	$167.5M
Depreciation and amortization	$82.8M	$55.4M	$27.2M	$81.0M
Net realized and unrealized (gains) losses on investments	$19.4M	$19.1M	$22.9M	($3.0M)
Deferred income taxes	($12.4M)	($8.2M)	($13.4M)	($27.4M)
Accounts receivable	($148.0M)	($112.9M)	($295.8M)	($69.9M)
Other current assets	($291.6M)	$37.8M	($50.1M)	($21.9M)
Other assets	$30.1M	($141.9M)	$3.5M	$81.4M
Accounts payable	($4.1M)	($3.8M)	$3.6M	($5.0M)
Income taxes payable	($49.6M)	($40.4M)	$327.6M	$27.6M
Other current liabilities	$257.4M	($49.4M)	$20.9M	($9.3M)
Other liabilities	($22.6M)	$113.4M	($7.6M)	($7.6M)
Other	($40.3M)	($16.9M)	($11.1M)	($25.4M)
Net Cash Provided by Operating Activities	$3.3B	$2.2B	$1.3B	$3.1B
Proceeds from maturities of available-for-sale marketable securities	$4.8M	$2.0M	$1.1M	$6.2M
Purchases of available-for-sale marketable securities	($4.9M)	($2.2M)	($800.0K)	($4.9M)
Purchases of property, net	($61.2M)	($45.4M)	($21.8M)	($51.0M)
Investments in privately-held equity investments	($11.7M)	($6.8M)	($1.5M)	($3.4M)
Net Cash Used in Investing Activities	($73.0M)	($52.4M)	($23.0M)	($53.1M)
Proceeds from debt, net of issuance costs	$0	$0	$0	$740.6M
Repayment of debt	$0	$0	$0	($750.0M)
Cash dividends	($3.6B)	($3.2B)	($2.7B)	($3.5B)
Repurchase of Class A common stock, including costs	($1.8B)	($1.2B)	($538.7M)	($8.2M)
Change in performance bond and guaranty fund contributions	($4.5B)	($1.5B)	$5.4B	$50.1B
Employee taxes paid on restricted stock vesting	($44.5M)	($22.2M)	($22.0M)	($31.0M)
Other	($9.0M)	($4.6M)	($4.4M)	($8.8M)
Net Cash (Used in) Provided by Financing Activities	($9.9B)	($6.0B)	$2.1B	$46.6B
Net change in cash, cash equivalents, restricted cash and restricted cash equivalents	($6.7B)	($3.8B)	$3.4B	$49.7B
Cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of period	$164.1B	$164.1B	$164.1B	$101.8B
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, End of Period	$157.4B	$160.3B	—	—
Cash and cash equivalents	$2.2B	$2.1B	$2.4B	$2.4B
Short-term restricted cash	$3.5M	$4.4M	$6.4M	$6.5M
Restricted cash and restricted cash equivalents (performance bonds and guaranty fund contributions)	$155.2B	$158.1B	$165.0B	$149.0B
Total	$157.4B	$160.3B	—	—
Income taxes paid, net of refunds	$1.0B	$689.7M	$42.7M	$855.2M
Interest paid	$116.5M	$70.2M	$46.3M	$111.7M

CME GROUP INC. score and earnings-call analysis · All covered companies

Figures as reported in SEC filings. General information, not investment advice.